Unison Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.9M Buy
57,154
+358
+0.6% +$35K 0.34% 37
2026
Q2
$5.88M Buy
56,796
+477
+0.8% +$42.6K 0.41% 27
2026
Q1
$4.04M Buy
56,319
+462
+0.8% +$35.6K 0.31% 39
2025
Q4
$4.43M Buy
55,857
+446
+0.8% +$35.2K 0.39% 33
2025
Q3
$4.18M Buy
55,411
+547
+1% +$37.5K 0.38% 33
2025
Q2
$3.78M Buy
54,864
+564
+1% +$37K 0.42% 36
2025
Q1
$3.68M Buy
+54,300
New +$3.25M 0.47% 37
2023
Q4
– Sell
-40,721
Closed -$2.84M – 182
2023
Q3
$2.84M Buy
40,721
+353
+0.9% +$25K 0.33% 38
2023
Q2
$2.79M Buy
40,368
+315
+0.8% +$22.4K 0.31% 41
2023
Q1
$2.98M Buy
40,053
+334
+0.8% +$28K 0.33% 34
2022
Q4
$3.7M Buy
39,719
+245
+0.6% +$23.6K 0.48% 24
2022
Q3
$3.76M Buy
39,474
+228
+0.6% +$22.6K 0.7% 19
2022
Q2
$3.64M Buy
39,246
+212
+0.5% +$20.7K 0.94% 15
2022
Q1
$3.95M Buy
39,034
+188
+0.5% +$19.8K 0.95% 15
2021
Q4
$4.01M Buy
38,846
+287
+0.7% +$26.5K 0.97% 17
2021
Q3
$3.27M Sell
38,559
-9,952
-21% -$834K 0.82% 21
2021
Q2
$4.05M Buy
+48,511
New +$3.97M 0.75% 21

Other funds holding CVS

Unison Advisors's CVS Position: Q3 2026 in Review

Unison Advisors increased its CVS Health (CVS) stake by 0.63% in Q3 2026, buying an estimated $35K and bringing the position to 57,154 shares worth $4.9M. The position accounts for 0.34% of the portfolio, ranked #37.

Unison Advisors first reported a position in CVS in Q2 2021 and has held it in 17 quarters since. The position peaked at $5.88M in Q2 2026. 1,136 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Unison Advisors held 57,154 shares of CVS Health worth $4.9M as of Q3 2026.
  • Unison Advisors bought 358 CVS Health shares in Q3 2026, an estimated $35K.
  • CVS Health made up 0.34% of Unison Advisors's portfolio in Q3 2026, its #37 holding.
  • Unison Advisors first reported a position in CVS Health in Q2 2021 and has held it in 17 quarters since.
  • Unison Advisors's CVS Health position peaked at $5.88M in Q2 2026.
  • 1,136 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Unison Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.